Can Vaccinations Improve Heart Failure Outcomes?

Mozaffarian, 2015, Heart disease and stroke statistics–2015 update: a report from the American Heart Association, Circulation, 131, e29, 10.1161/CIR.0000000000000152 Heidenreich, 2011, Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association, Circulation, 123, 933, 10.1161/CIR.0b013e31820a55f5 Braunwald, 2013, Heart failure, J Am Coll Cardiol HF, 1, 1 Steinberg, 2012, Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes, Circulation, 126, 65, 10.1161/CIRCULATIONAHA.111.080770 Heidenreich, 2013, Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association, Circ Heart Fail, 6, 606, 10.1161/HHF.0b013e318291329a Ajani, 2005, Examining the coverage of influenza vaccination among people with cardiovascular disease in the United States, Am Heart J, 149, 254, 10.1016/j.ahj.2004.07.028 Chang, 2016, The association between influenza infection, vaccination, and atrial fibrillation: a nationwide case-control study, Heart Rhythm, 13, 1189, 10.1016/j.hrthm.2016.01.026 Alon, 2013, Predictors and outcomes of infection-related hospital admissions of heart failure patients, PloS One, 8, e72476, 10.1371/journal.pone.0072476 Fonarow, 2008, Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF, Arch Intern Med, 168, 847, 10.1001/archinte.168.8.847 Centers for Disease Control and Prevention (CDC). Estimated Influenza Illnesses and Hospitalizations Averted by Vaccination—United States, 2014–15 Influenza Season. 2015. Available at: https://www.cdc.gov/flu/about/disease/2014-15.htm. Accessed July 10, 2016 McElhaney, 2004, Effect of congestive heart failure on humoral and ex vivo cellular immune responses to influenza vaccination in older adults, Vaccine, 22, 681, 10.1016/j.vaccine.2003.08.032 Vu, 2002, A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community, Vaccine, 20, 1831, 10.1016/S0264-410X(02)00041-5 2015 Metersky, 2012, Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza, Int J Infect Dis, 16, e321, 10.1016/j.ijid.2012.01.003 Shahangian, 2009, Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice, J Clin Invest, 119, 1910, 10.1172/JCI35412 Tomczyk, 2014, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged >/=65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Morb Mortal Wkly Rep, 63, 822 Kobayashi, 2015, Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Morb Mortal Wkly Rep, 64, 944, 10.15585/mmwr.mm6434a4 Harper, 2004, Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 53, 1 Smith, 2011, AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation, J Am Coll Cardiol, 58, 2432, 10.1016/j.jacc.2011.10.824 Yancy, 2013, 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, J Am Coll Cardiol, 62, e147, 10.1016/j.jacc.2013.05.019 Lindenfeld, 2010, HFSA 2010 Comprehensive Heart Failure Practice Guideline, J Card Fail, 16, e1, 10.1016/j.cardfail.2010.04.004 Perk, 2012, Atherosclerosis, 223, 1, 10.1016/j.atherosclerosis.2012.05.007 Libby, 2005, Pathophysiology of coronary artery disease, Circulation, 111, 3481, 10.1161/CIRCULATIONAHA.105.537878 Berliner, 2001, Evidence for a role of phospholipid oxidation products in atherogenesis, Trends Cardiovasc Med, 11, 142, 10.1016/S1050-1738(01)00098-6 Danesh, 1998, Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies, JAMA, 279, 1477, 10.1001/jama.279.18.1477 Mendall, 1997, Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease, Heart (British Cardiac Society), 78, 273 Kumar, 1996, Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum, J Exp Med, 183, 949, 10.1084/jem.183.3.949 Mann, 2002, Inflammatory mediators and the failing heart: past, present, and the foreseeable future, Circ Res, 91, 988, 10.1161/01.RES.0000043825.01705.1B Levine, 1990, Elevated circulating levels of tumor necrosis factor in severe chronic heart failure, N Engl J Med, 323, 236, 10.1056/NEJM199007263230405 Oral, 1997, Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte, J Biol Chem, 272, 4836, 10.1074/jbc.272.8.4836 Gulick, 1989, Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness, Proc Natl Acad Sci U S A, 86, 6753, 10.1073/pnas.86.17.6753 Balligand, 1993, Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium, J Clin Invest, 91, 2314, 10.1172/JCI116461 Van Lenten, 2001, High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection, Circulation, 103, 2283, 10.1161/01.CIR.103.18.2283 Carty, 2006, Inflammatory response after influenza vaccination in men with and without carotid artery disease, Arterioscler Thromb Vasc Biol, 26, 2738, 10.1161/01.ATV.0000248534.30057.b5 Posthouwer, 2004, Influenza and pneumococcal vaccination as a model to assess C-reactive protein response to mild inflammation, Vaccine, 23, 362, 10.1016/j.vaccine.2004.05.035 Binder, 2003, Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL, Nat Med, 9, 736, 10.1038/nm876 Caligiuri, 2007, Phosphorylcholine-targeting immunization reduces atherosclerosis, J Am Coll Cardiol, 50, 540, 10.1016/j.jacc.2006.11.054 Hebert, 2010, Prevalence of vaccination rates in systolic heart failure: a prospective study of 549 patients by age, race, ethnicity, and sex in a heart failure disease management program, Congest Heart Fail, 16, 278, 10.1111/j.1751-7133.2010.00190.x Vardeny, 2016, Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF trial, J Am Coll Cardiol HF, 4, 152 Gurfinkel, 2004, Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study, Eur Heart J, 25, 25, 10.1016/j.ehj.2003.10.018 Ciszewski, 2008, Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study, Eur Heart J, 29, 1350, 10.1093/eurheartj/ehm581 Phrommintikul, 2011, Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome, Eur Heart J, 32, 1730, 10.1093/eurheartj/ehr004 Udell, 2013, Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis, JAMA, 310, 1711, 10.1001/jama.2013.279206 Nichol, 2003, Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly, N Engl J Med, 348, 1322, 10.1056/NEJMoa025028 Davis, 2001, Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan, Med Care, 39, 1273, 10.1097/00005650-200112000-00003 Nichol, 1994, The Efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community, N Engl J Med, 331, 778, 10.1056/NEJM199409223311206 Kopel, 2014, Influenza vaccine and survival in acute heart failure, Eur J Heart Fail, 16, 264, 10.1002/ejhf.14 Mohseni, 2016, Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study, Eur Heart J, 10.1093/eurheartj/ehw411 2013, Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices—United States, 2013–2014, MMWR Recomm Rep, 62, 1 DiazGranados, 2014, Efficacy of high-dose versus standard-dose influenza vaccine in older adults, N Engl J Med, 371, 635, 10.1056/NEJMoa1315727 Vardeny, 2009, Decreased immune responses to influenza vaccination in patients with heart failure, J Card Fail, 15, 368, 10.1016/j.cardfail.2008.11.009 Van Ermen, 2013, Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study, Eur J Heart Fail, 15, 560, 10.1093/eurjhf/hfs207 Musher, 2007, The association between pneumococcal pneumonia and acute cardiac events, Clin Infect Dis, 45, 158, 10.1086/518849 Ren, 2015, Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis, Open Heart, 2, e000247, 10.1136/openhrt-2015-000247 Lamontagne, 2008, Pneumococcal vaccination and risk of myocardial infarction, CMAJ, 179, 773, 10.1503/cmaj.070221 Tseng, 2010, Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men, JAMA, 303, 1699, 10.1001/jama.2010.529 Fedson, 2000, Hospital-based influenza and pneumococcal vaccination: Sutton's Law applied to prevention, Infect Control Hosp Epidemiol, 21, 692, 10.1086/501716 Kale, 2012, Visits for primary care services to primary care and specialty care physicians, 1999 and 2007, Arch Intern Med, 172, 1421, 10.1001/archinternmed.2012.3207 Massoudi, 1999, Assessing immunization performance of private practitioners in Maine: impact of the assessment, feedback, incentives, and exchange strategy, Pediatrics, 103, 1218, 10.1542/peds.103.6.1218 Fairbrother, 1999, The impact of physician bonuses, enhanced fees, and feedback on childhood immunization coverage rates, Am J Public Health, 89, 171, 10.2105/AJPH.89.2.171